{
    "nct_id": "NCT06733350",
    "official_title": "Investigating the Effect of Testosterone Replacement Therapy Among Hypogonadal Men With Localized Prostate Cancer on Active Surveillance",
    "inclusion_criteria": "* Men aged â‰¥ 18 years\n* Men with localized prostate cancer are eligible for active surveillance (National Comprehensive Cancer Network [NCCN] very low, low, and intermediate favorable risk group)\n* Participant must understand the investigational nature of this study and sign an independent ethics committee/institutional review board approved written informed consent form prior to receiving any study related procedure\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Patients with NCCN intermediate unfavorable, high risk, or very high-risk localized prostate cancer\n* Patients with contraindications to TRT, which include,\n\n  * Locally advanced or metastatic prostate cancer\n  * Male breast cancer\n  * Men with an active desire to have children\n  * Hematocrit levels > 54% or baseline hematocrit of 48-50%\n  * Uncontrolled or poorly controlled congestive heart failure\n  * IPSS score > 19\n  * Family history of venous thromboembolism\n* Unwilling or unable to follow protocol requirements\n* Any condition which in the investigator's opinion deems the participant an unsuitable candidate to participate in the study",
    "miscellaneous_criteria": ""
}